Merck Kgaa
(MRK.D.DX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 5,352,000 | 5,120,000 | 5,225,000 | 5,173,000 | 5,302,000 |
| Cost of Goods | 2,119,000 | 2,111,000 | 2,327,000 | 2,162,000 | 2,139,000 |
| Gross Profit | 3,233,000 | 3,009,000 | 2,898,000 | 3,011,000 | 3,163,000 |
| Operating Expenses | 2,440,000 | 2,079,000 | 2,348,000 | 1,999,000 | 2,183,000 |
| Operating Income | 793,000 | 930,000 | 550,000 | 1,012,000 | 980,000 |
| Interest Expense | 72,000 | 74,000 | 38,000 | 84,000 | 149,000 |
| Other Income | 64,000 | 43,000 | 129,000 | 9,000 | 63,000 |
| Pre-tax Income | 785,000 | 899,000 | 641,000 | 937,000 | 894,000 |
| Income Tax | 180,000 | 200,000 | 53,000 | 197,000 | 188,000 |
| Net Income Continuous | 605,000 | 699,000 | 588,000 | 740,000 | 706,000 |
| Minority Interests | 2,000 | -5,000 | -2,000 | -2,000 | -3,000 |
| Net Income | $607,000 | $694,000 | $586,000 | $739,000 | $704,000 |
| EPS Basic Total Ops | 1.40 | 1.60 | 1.34 | 1.70 | 1.62 |
| EPS Basic Continuous Ops | 1.40 | 1.60 | 1.34 | 1.70 | 1.62 |
| EPS Diluted Total Ops | 1.40 | 1.60 | 1.34 | 1.70 | 1.62 |
| EPS Diluted Continuous Ops | 1.40 | 1.60 | 1.34 | 1.70 | 1.62 |
| EBITDA(a) | $1,537,000 | $1,427,000 | $1,186,000 | $1,456,000 | $1,525,000 |